<bill session="105" type="h" number="1294" updated="2013-07-14T18:50:08-04:00">
  <state datetime="1997-04-10">REFERRED</state>
  <status>
    <introduced datetime="1997-04-10"/>
  </status>
  <introduced datetime="1997-04-10"/>
  <titles>
    <title as="introduced" type="official">To amend title 10, United States Code, to require the Secretary of Defense to provide to members of the Armed Forces who receive an investigational new drug relevant information regarding the drug, including the possible side effects of the drug.</title>
  </titles>
  <sponsor id="400215"/>
  <cosponsors/>
  <actions>
    <action state="REFERRED" datetime="1997-04-10">
      <text>Referred to the House Committee on National Security.</text>
    </action>
    <action datetime="1997-04-21">
      <text>Executive Comment Requested from DOD.</text>
      <committee name="House Committee on National Security"/>
    </action>
    <action datetime="1997-04-21">
      <text>Referred to the Subcommittee on Military Personnel.</text>
      <committee name="House Committee on National Security"/>
    </action>
    <action datetime="1997-11-06">
      <text>See H.R.1119.</text>
      <committee name="House Committee on National Security"/>
    </action>
  </actions>
  <committees>
    <committee code="HSAS" name="House National Security" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSAS02" subcommittee="Military Personnel" name="House National Security"/>
  </committees>
  <relatedbills>
    <bill relation="unknown" session="105" type="h" number="1119"/>
  </relatedbills>
  <subjects>
    <term name="Armed forces and national security"/>
    <term name="Clinical trials"/>
    <term name="Congress"/>
    <term name="Congressional reporting requirements"/>
    <term name="Drugs"/>
    <term name="Government operations and politics"/>
    <term name="Government paperwork"/>
    <term name="Health"/>
    <term name="Informed consent (Medical law)"/>
    <term name="Law"/>
    <term name="Military medicine"/>
    <term name="Pharmaceutical research"/>
    <term name="Science, technology, communications"/>
  </subjects>
  <amendments/>
  <summary>4/10/1997--Introduced.
Amends provisions governing the Civilian Health and Medical Program of the Uniformed Services (CHAMPUS) to provide that, whenever the Secretary of Defense requests or requires a member of the armed forces to receive an investigational new drug, the Secretary shall provide such member a notice identifying such drug as an investigational new drug, giving the reasons why such drug is being administered and disclosing possible side effects. Requires such notice to be provided before such drug is administered, if practicable, but in no case no later than 30 days afterwards. Requires the Secretary to report to the Congress the reasons a form of notice other than written notice is used.</summary>
</bill>
